Prutitis vulvae 10 marks obgy pg answer
pruritus vulvae lichen sclerosus vulva clinical appearance

A three-panel figure demonstrating clinical and histological features of lichen sclerosus of the vulva. Panel A is a clinical colposcopy photograph showing the macroscopic appearance of the vulvar region, with a green circle indicating the specific site of interest. Panel B is a cross-sectional optical coherence tomography (OCT) image of the affected tissue. It shows well-defined stratification between the epithelium and stroma with uniform optical scattering. A key diagnostic feature highlighted is the loss of the serrated rete peg architecture at the epithelial-stromal junction. A red arrow indicates a hyper-reflective surface layer corresponding to hyperkeratosis, and a red bracket denotes the epithelial thickness. Panel C is a corresponding hematoxylin and eosin (H&E) stained histological section (150 μm scale) that correlates with the OCT findings. It confirms the presence of surface keratinization (arrow), a thinned or flattened epithelial layer (bracket), and the absence of rete pegs, consistent with lichen sclerosus pathology. This comparison serves as a diagnostic reference for utilizing non-invasive OCT imaging in identifying sub-surface morphological changes in gynecological dermatological conditions.

This clinical photograph demonstrates advanced lichen sclerosus affecting the female vulva, characterized by severe architectural distortion. The primary finding is the complete fusion and agglutination of the labia majora and labia minora, resulting in the total obliteration of the interlabial sulci. The skin exhibits hallmark signs of chronic vulvar dermatosis, including diffuse pallor, waxy texture, and areas of shiny, 'parchment-like' scarring (atrophy). The clitoral hood is buried under fused tissue, and the urethral and vaginal openings are significantly narrowed and obscured, leaving only a small central introitus visible. Inflammatory changes are noted by localized erythema and vascular prominence near the residual opening. These features represent the end-stage morphological changes associated with chronic inflammation, leading to extensive scarring and loss of normal anatomical landmarks, which clinically manifest as severe pruritus, pain, and dyspareunia.

This clinical photograph displays the vulvar and perianal regions of a patient diagnosed with lichen sclerosus. The image illustrates characteristic dermatological changes, primarily marked by porcelain-white patches of hypopigmentation (leukoplakia) and skin thinning. These hypopigmented lesions are distributed in a classic 'figure-of-eight' pattern, encircling both the vulva and the perianal area. There is evidence of architectural distortion, including possible atrophy or resorption of the labia minora and narrowing of the introitus. The surrounding skin shows mottled pigmentation and textural changes consistent with chronic inflammation. The medical specialty involved is gynecology or dermatology, and the image serves as an educational tool for identifying the morphological features of vulvar lichen sclerosus, such as the characteristic whitening, thinning, and anatomical scarring that can lead to symptoms like pruritus and dyspareunia.
| Condition | Mechanism |
|---|---|
| Diabetes mellitus | Glycosuria promotes Candida overgrowth; altered immune response |
| Hepatic disease / Obstructive jaundice | Bile salt deposition in skin |
| Chronic renal failure | Uraemia causing cutaneous nerve stimulation |
| Hypothyroidism / Myxoedema | Dry skin |
| Iron deficiency anaemia | Epithelial changes |
| Polycythaemia vera | Aquagenic pruritus mechanism |
| Drugs | Tamoxifen - causes vulvar itch, vaginal dryness as adverse effect |
| Cause | Treatment |
|---|---|
| Candidiasis | Topical azole (clotrimazole, miconazole) or oral fluconazole 150 mg single dose; treat partner if recurrent |
| Trichomonas | Metronidazole 400 mg BD × 7 days or 2 g single dose; treat partner |
| BV | Metronidazole or clindamycin |
| Lichen sclerosus | High-potency topical steroids (clobetasol propionate) - pulsed dosing; topical tacrolimus or pimecrolimus as steroid-sparing agents |
| Contact dermatitis | Identify and remove allergen (patch testing); topical corticosteroids |
| Lichen planus | High-potency topical steroids; other options in refractory cases |
| LSC | Topical steroids + breaking the itch-scratch cycle |
| Psoriasis | Topical steroids, calcipotriol, phototherapy |
| Atrophic vaginitis (post-menopausal) | Local estrogen cream/pessary; systemic HRT if appropriate |
| Psychogenic / Neuropathic | Topical lidocaine, pramoxine; oral tricyclic antidepressant (amitriptyline); gabapentin |
| Extramammary Paget's / VIN / Malignancy | Surgical excision, wide local excision; oncology referral |
